Novel inhalation formulation of colistin and combination therapy against Gram-negative 'superbugs'.

  • Chan, Hak-Kim (Primary Chief Investigator (PCI))
  • Zhou, Qi (Chief Investigator (CI))
  • Li, Jian (Chief Investigator (CI))
  • Fouras, Andreas Christos (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/01/1431/12/16

Funding

  • National Health and Medical Research Council (NHMRC) (Australia): AUD303,981.00